APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L108. A total of 56 filers reported holding APTEVO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $36,000 | -53.2% | 61,727 | -28.8% | 0.00% | -50.0% |
| Q2 2019 | $77,000 | -1.3% | 86,727 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $78,000 | -29.1% | 86,727 | 0.0% | 0.01% | -28.6% |
| Q4 2018 | $110,000 | -75.1% | 86,727 | 0.0% | 0.01% | -63.2% |
| Q3 2018 | $441,000 | -25.5% | 86,727 | -27.0% | 0.02% | -32.1% |
| Q2 2018 | $592,000 | -8.5% | 118,736 | -40.0% | 0.03% | -12.5% |
| Q1 2018 | $647,000 | -31.1% | 197,986 | -10.6% | 0.03% | -30.4% |
| Q4 2017 | $939,000 | +35.7% | 221,380 | -26.7% | 0.05% | +35.3% |
| Q3 2017 | $692,000 | -5.6% | 301,980 | -14.7% | 0.03% | -5.6% |
| Q2 2017 | $733,000 | +0.5% | 353,977 | 0.0% | 0.04% | -18.2% |
| Q1 2017 | $729,000 | -15.6% | 353,977 | 0.0% | 0.04% | -6.4% |
| Q4 2016 | $864,000 | -4.6% | 353,977 | 0.0% | 0.05% | +6.8% |
| Q3 2016 | $906,000 | – | 353,977 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,413,421 | $2,008,000 | 1.95% |
| Worth Venture Partners, LLC | 375,669 | $221,000 | 0.13% |
| Park West Asset Management LLC | 1,000,000 | $588,000 | 0.03% |
| ALGERT GLOBAL LLC | 74,906 | $44,000 | 0.02% |
| Sessa Capital IM, L.P. | 180,149 | $106,000 | 0.01% |
| ATLAS CAPITAL ADVISORS LLC | 49,045 | $28,858,000 | 0.01% |
| Point72 Asset Management, L.P. | 2,450,000 | $1,442,000 | 0.01% |
| Alyeska Investment Group, L.P. | 750,000 | $441,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 78,000 | $46,000 | 0.00% |
| A.R.T. Advisors, LLC | 69,934 | $41,000 | 0.00% |